GottliebJ.J., WashenikK., ChachouaA., Friedman-KienA.: Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin. Lancet, 350: 1363–1364, 1997.
2.
BrambillaL., LabiancaR., FerrucciS.M., TaglioniM., BarreschiV.: Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology, 202: 119–122, 2001.
3.
GrunewaldR., AbbruzzeseJ.L., TarassoffP., PlunkettW.: Saturation of 2′,2′- difluorodeoxycytidine 5′-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine. Cancer Chemother Pharmacol, 27: 258–262, 1991.
4.
CarteiG., BinatoS., TrestinA.R., CeravoloR., SalmasoF., PastorelliD., ZustovichF., PaganelliF., MattiazziM., VattemiE.: Phase II trial of gemcitabine as prolonged infusion in metastatic non-small-cell lung cancer. Lung Cancer, 41 (Suppl 2) s229: 545 (abstract), 2003.
5.
CeribelliA., GridelliC., De MarinisF., FabiA., GamucciT., CortesiE., BarduagniM., AntimiM., MaioneP., MigliorinoM.R., GiannarelliD., CognettiF.: Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin. Cancer, 98: 337–343, 2003.
6.
TemperoM., PlunkettW., Ruiz Van HaperenV., HainsworthJ., HochsterH., LenziR., AbbruzzeseJ.: Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol, 21: 3402–3408, 2003.
7.
NowakA.K., RobinsonB.W., LakeR.A.: Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res, 63: 4490–4496, 2003.
